Allogeneic stem-cell transplantation in renal-cell carcinoma.

B. M. Hayes-Lattin; R. T. Maziarz; T. M. Beer

doi:10.1007/s11912-001-0030-7

Allogeneic stem-cell transplantation in renal-cell carcinoma.

B. M. Hayes-Lattin, R. T. Maziarz, T. M. Beer

Research output: Contribution to journal › Review article › peer-review

4 Scopus citations

Abstract

Metastatic renal-cell carcinoma (RCC) remains resistant to nearly all standard cytotoxic therapies, but immune-based cytokine therapies benefit a small minority of patients with advanced RCC. Nonmyeloablative allogeneic stem-cell transplantation is a novel approach to harnessing the immune system to combat this cancer. The strategy relies on a T-cell graft-versus-malignancy effect mediated by donor T cells. Preliminary work in using nonmyeloablative allogeneic stem-cell transplant in RCC has identified a graft-versus-RCC effect and yielded encouraging clinical responses.

Original language	English (US)
Pages (from-to)	433-437
Number of pages	5
Journal	Current oncology reports
Volume	3
Issue number	5
DOIs	https://doi.org/10.1007/s11912-001-0030-7
State	Published - 2001

ASJC Scopus subject areas

Oncology

Access to Document

10.1007/s11912-001-0030-7

Cite this

@article{0094c5523525426c998bea1becbe4089,

title = "Allogeneic stem-cell transplantation in renal-cell carcinoma.",

abstract = "Metastatic renal-cell carcinoma (RCC) remains resistant to nearly all standard cytotoxic therapies, but immune-based cytokine therapies benefit a small minority of patients with advanced RCC. Nonmyeloablative allogeneic stem-cell transplantation is a novel approach to harnessing the immune system to combat this cancer. The strategy relies on a T-cell graft-versus-malignancy effect mediated by donor T cells. Preliminary work in using nonmyeloablative allogeneic stem-cell transplant in RCC has identified a graft-versus-RCC effect and yielded encouraging clinical responses.",

author = "Hayes-Lattin, {B. M.} and Maziarz, {R. T.} and Beer, {T. M.}",

note = "Funding Information: 25. Medical Research Council Renal Cancer Collaborators: Inter-feron-alpha and survival in metastatic renal carcinoma: early results of a randomised controlled trial. Lancet 1999, 353:14–17.",

year = "2001",

doi = "10.1007/s11912-001-0030-7",

language = "English (US)",

volume = "3",

pages = "433--437",

journal = "Current oncology reports",

issn = "1523-3790",

publisher = "Current Science, Inc.",

number = "5",

}

TY - JOUR

T1 - Allogeneic stem-cell transplantation in renal-cell carcinoma.

AU - Hayes-Lattin, B. M.

AU - Maziarz, R. T.

AU - Beer, T. M.

N1 - Funding Information: 25. Medical Research Council Renal Cancer Collaborators: Inter-feron-alpha and survival in metastatic renal carcinoma: early results of a randomised controlled trial. Lancet 1999, 353:14–17.

PY - 2001

Y1 - 2001

N2 - Metastatic renal-cell carcinoma (RCC) remains resistant to nearly all standard cytotoxic therapies, but immune-based cytokine therapies benefit a small minority of patients with advanced RCC. Nonmyeloablative allogeneic stem-cell transplantation is a novel approach to harnessing the immune system to combat this cancer. The strategy relies on a T-cell graft-versus-malignancy effect mediated by donor T cells. Preliminary work in using nonmyeloablative allogeneic stem-cell transplant in RCC has identified a graft-versus-RCC effect and yielded encouraging clinical responses.

AB - Metastatic renal-cell carcinoma (RCC) remains resistant to nearly all standard cytotoxic therapies, but immune-based cytokine therapies benefit a small minority of patients with advanced RCC. Nonmyeloablative allogeneic stem-cell transplantation is a novel approach to harnessing the immune system to combat this cancer. The strategy relies on a T-cell graft-versus-malignancy effect mediated by donor T cells. Preliminary work in using nonmyeloablative allogeneic stem-cell transplant in RCC has identified a graft-versus-RCC effect and yielded encouraging clinical responses.

UR - http://www.scopus.com/inward/record.url?scp=0035461354&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035461354&partnerID=8YFLogxK

U2 - 10.1007/s11912-001-0030-7

DO - 10.1007/s11912-001-0030-7

M3 - Review article

C2 - 11489245

AN - SCOPUS:0035461354

SN - 1523-3790

VL - 3

SP - 433

EP - 437

JO - Current oncology reports

JF - Current oncology reports

IS - 5

ER -

Allogeneic stem-cell transplantation in renal-cell carcinoma.

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this